A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and Administered Via a Syringe Relative to the Vonoprazan Tablet in Healthy Participants

NCT06831344 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Vonoprazan ODT-1 or ODT-2 without Water
DRUG: Vonoprazan ODT-1 or ODT-2 with Water
DRUG: Vonoprazan (Reference)

Sponsor

Phathom Pharmaceuticals, Inc.